Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
about
The pituri story: a review of the historical literature surrounding traditional Australian Aboriginal use of nicotine in Central AustraliaToxicity of amphetamines: an updateOccupational gradients in smoking behavior and exposure to workplace environmental tobacco smoke: the multi-ethnic study of atherosclerosisPharmacological interventions for smoking cessation: an overview and network meta-analysisPharmacological interventions for smoking cessation: an overview of reviewsNicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboonsCrucial roles of the CHRNB3-CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future researchProfile of women who carried out smoking cessation treatment: a systematic reviewConceptualizing analyses of ecological momentary assessment dataPredictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy.Electronic cigarettes. A position statement of the forum of international respiratory societiesLow dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in miceThe serotonin transporter gene and startle response during nicotine deprivationSubtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.Smoking patterns and stimulus control in intermittent and daily smokers.Adverse childhood experiences are associated with the risk of lung cancer: a prospective cohort study.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceSynthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.Ten critical reasons for treating tobacco dependence in inpatient psychiatryDo ethnicity and gender moderate the influence of posttraumatic stress disorder on time to smoking lapse?Sexually diergic, dose-dependent hypothalamic-pituitary-adrenal axis responses to nicotine in a dynamic in vitro perfusion system.Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism.Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: preliminary findings.Tobacco-smoking-related differential DNA methylation: 27K discovery and replicationMenthol's potential effects on nicotine dependence: a tobacco industry perspective.Association of daily tar and nicotine intake with incident myocardial infarction: results from the population-based MONICA/KORA Augsburg Cohort Study 1984-2002.Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats.Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in miceRoute of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusionNeurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.Examining vulnerability to smokeless tobacco use among adolescents and adults meeting diagnostic criteria for major depressive disorderCotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adultsA novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo.Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.Reward, addiction, withdrawal to nicotine.Time to first cigarette after waking predicts cotinine levels.Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial.A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction.Overview of Electronic Nicotine Delivery Systems: A Systematic Review.Inhalation of Alcohol Vapor: Measurement and Implications.
P2860
Q21203602-90F8B4DC-7FF5-4F86-98A5-763251DDF2FEQ22252794-8B8651E6-7EA5-41AE-AB4E-CBD666135D72Q23915849-107BB83C-3678-4CE3-876F-BF40676D1A03Q24202961-D5873012-BA33-4BD2-B639-662EEAB42017Q24234851-1DD6F198-4ACC-4DA7-8863-193001C95D17Q24608685-3E6F892A-1FA4-427F-ADC9-705CB3F494E7Q26744123-BB123E37-EC27-444B-8A0F-0E8B204168A5Q26801555-BC3E5638-2BA2-4D40-992B-B0828D8F03C4Q26849763-47CB4EA3-DB50-45FA-A1FD-4161A113C52BQ27312260-73E28681-FC25-4EFF-B28A-A33D0D9FB611Q28243586-8FEE077F-D94C-408B-9A34-417728C311EAQ28484969-DED6F7D7-EC07-4E3C-99D8-977BBD90D50DQ30466508-F702ED84-2CA4-48D9-9999-DDEE71679BE1Q30487079-D96C71F9-A14B-418E-94D0-24D4829B2B32Q31152661-B7B95A5A-0D55-4921-878C-465DB2271AECQ33525163-1C2794F7-DD48-4EF7-BAB4-ED75913B9EC1Q33703839-A4F86B75-C69B-4BAB-B459-D56A626B11EAQ33738559-1E160480-F0A8-47E1-B6D7-DEE3D3CC0EA6Q33750079-9184E8ED-3D62-4DEB-BD54-7EF07F09F50BQ33782612-87230320-5991-4F14-8101-360AFD06BC52Q33820485-EBB326F0-091F-45C2-8C05-3539A942E39DQ33853981-7DC301E3-7719-413E-9D0A-2C9C1C2F078CQ33859178-E4F92995-2C04-4068-901E-69766478BAD1Q33860650-F8745B3E-A2EF-4C52-9E24-A9EB31F7990AQ33877118-035301A6-BE12-4BFC-AB1E-5BEE1400CE1AQ33889942-5077C88B-E79B-4578-96A8-77A08DFC2900Q33921387-4A7A1F1B-46C6-4BC9-BEB0-B13C3627CA51Q33933963-D1A21271-E41A-4062-860F-2131C1F87EBEQ33939461-2573B185-7504-4740-9B84-2B4100316D83Q34012381-15AB2C46-D09C-497C-B465-00384297BE9BQ34013253-5611EDE6-C1A8-4A94-A4DA-F4CB5B238DD4Q34064504-248A162B-241E-412B-80E1-7CB0D48AB66BQ34068238-BD8157E6-4496-4134-AC19-335500859293Q34164440-48A4390C-EFA2-4DD3-AA1E-BA390EFF78A6Q34173418-74C2D9BD-061C-4D36-918E-0F8ED856153EQ34187411-4D1B1E48-D201-46D3-9843-4999E9A4AA60Q34253442-BC7FE428-9B5B-46D1-A13F-0B8BA8B14B3CQ34480225-4433B6B2-4750-4309-A059-86372E1A7B4AQ34546578-79684203-441A-491B-AC80-009C35693A84Q34548568-D7CA1E73-5A19-4758-803F-996D67E871F7
P2860
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@ast
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@en
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@nl
type
label
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@ast
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@en
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@nl
prefLabel
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@ast
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@en
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@nl
P356
P1476
Clinical pharmacology of nicot ...... nd treating tobacco addiction.
@en
P2093
N L Benowitz
P2860
P304
P356
10.1038/CLPT.2008.3
P407
P577
2008-02-27T00:00:00Z